Abstract
One of the most intriguing facets of neoplastic transformation, whether induced by chemical carcinogens or oncogenic viruses, is the expression at the surface membrane of the transformed cell of neoantigens which are not expressed on their normal cell counterparts, at least in the adult host. However, it is now over two decades since the first acceptable report on tumor-associated rejection antigens on 3-methylcholanthrene-induced murine sarcomas (Foley, 1953), and yet only relatively recently have significant advances been made in the study of the chemistry and biology of these tumor cell components. This is due to some extent to an initial reluctance to accept that the immunity elicited against transplanted tumor cells in highly inbred (syngeneic) animals was a tumor-specific phenomenon and was not due to weak alloantigen responses. Furthermore, only relatively recently has it been possible to detect and measure in vitro cell-mediated and humoral tumor-immune responses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abelev, G. I., 1974, α-Fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues, Transplant. Rev. 20:3.
Abelev, G. I., Perova, S. D., Khramkova, N. I., Postnikova, Z. A., and Irlin, I. S., 1963, Production of embryonal α-globulin by transplantable mouse hepatomas, Transplantation 1:174.
Albright, N. L., and Myers, G. H., 1972, Specific antigens of a chemically induced tumor: Detection by complement fixation, J. Natl. Cancer Inst. 49:295.
Apffel, C. A., Arnason, B. G., and Peters, J. H., 1966, Induction of tumor immunity with tumor cells treated with iodoacetate, Nature (London) 209:694.
Baldwin, R. W., 1955, Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of implanted tumours, Br. J. Cancer 9:652.
Baldwin, R. W., 1973, Immunological aspects of chemical carcinogenesis, Advan. Cancer Res. 18:1.
Baldwin, R. W., and Barker, C. R., 1967a, Tumour-specific antigenicity of aminoazo-dye-induced rat hepatomas, Int. J. Cancer 2:355.
Baldwin, R. W., and Barker, C. R., 1967b, Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata, Br. J. Cancer 21:793.
Baldwin, R. W., and Barker, C. R., 1967c, Antigenic composition of transplanted rat hepatomas originally induced by 4-dimethylaminoazobenzene, Br. J. Cancer 21:338.
Baldwin, R. W., and Embleton, M. J., 1969, Immunology of 2-acetylaminofluorene-induced rat mammary adenocarcinomas, Int. J. Cancer 4:47.
Baldwin, R. W., and Embleton, M. J., 1971a, Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas, Int. J. Cancer 7:17.
Baldwin, R. W., and Embleton, M. J., 1971b, Tumor-specific antigens in 2-acetylamino-fluorene-induced rat hepatomas and related tumors, Israel J. Med. Sci. 7:144.
Baldwin, R. W., and Embleton, M. J., 1974, Neoantigens on spontaneous and carcinogen-induced rat tumours defined by in vitro lymphocytotoxicity assays, Int. J. Cancer 13:433.
Baldwin, R. W., and Glaves, D., 1972, Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma, Clin. Exp. Immunol. 11:51.
Baldwin, R. W., and Moore, M., 1969, Isolation of membrane-associated tumour-specific antigen from an aminoazo-dye-induced rat hepatoma, Int. J. Cancer 4:753.
Baldwin, R. W., and Moore, M., 1971, Tumour-specific antigens and tumour-host interactions, in: Immunological Tolerance to Tissue Antigens (N. W. Nisbet and M. W. Elves, eds.), pp. 299–313, Orthopaedic Hospital, Oswestry, England.
Baldwin, R. W., and Pimm, M. V., 1973, BCG immunotherapy of a rat sarcoma, Br. J. Cancer 28:281.
Baldwin, R. W., and Price, M. R., 1976, Immunology of experimental liver cancer, in: Liver Cell Cancer (H. M. Cameron, G. P. Warwick, and C. A. Linsell, eds.), Elsevier, Amsterdam.
Baldwin, R. W., and Vose, B. M., 1974, Embryonic antigen expression on 2-acetylaminofluorene induced and spontaneously arising rat tumours, Br. J. Cancer 30:209.
Baldwin, R. W., and Vose, B. M., 1975, The expression of a phase specific foetal antigen on rat embryo cells, Transplantation 18:525.
Baldwin, R. W., Barker, C. R., Embleton, M. J., Glaves, D., Moore, M., and Pimm, M. V., 1971a, Demonstration of cell-surface antigens on chemically induced tumors, Ann. N.Y. Acad. Sci. 177:268.
Baldwin, R. W., Glaves, D., and Pimm, M. V., 1971b, Tumor-associated antigens as expressions of chemically-induced neoplasia and their involvement in tumor-host interactions, in: Progress in Immunology (B. Amos, ed.), pp. 907–920, Academic Press, New York.
Baldwin, R. W., Glaves, D., Harris, J. R., and Price, M. R., 1971c, Tumor-specific antigens associated with aminoazo dye-induced rat hepatomas, Transplant. Proc. 3:1189.
Baldwin, R. W., Glaves, D., Pimm, M. V., and Vose, B. M., 1972a, Tumour specific and
embryonic antigen expression on chemically induced rat tumours, Ann. Inst. Pasteur 122:715.
Baldwin, R. W., Harris, J. R., and Price, M. R., 1972b, Isolation of plasma-membrane-associated tumor-specific antigen from rat hepatoma cells, Biochem. J. 128:130.
Baldwin, R. W., Glaves, D., and Vose, B. M., 1972c, Embryonic antigen expression in chemically induced rat hepatomas and sarcomas, Int. J. Cancer 10:233.
Baldwin, R. W., Price, M. R., and Robins, R. A., 1972d, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature (London) New Biol. 238:185.
Baldwin, R. W., Embleton, M. J., and Robins, R. A., 1973a, Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status, Int. J. Cancer 11:1.
Baldwin, R. W., Harris, J. R., and Price, M. R., 1973b, Fractionation of plasma membrane-associated tumour specific antigen from an aminoazo dye-induced rat hepatoma, Int. J. Cancer 11:385.
Baldwin, R. W., Price, M. R., and Robins, R. A., 1973c, Characterization of serum factors blocking lymphocyte cytotoxicity for tumor cells, in: 26th M. D. Anderson Annual Symposium on Fundamental Cancer Research pp. 205–222. Williams and Wilkins, Baltimore.
Baldwin, R. W., Price, M. R., and Robins, R. A., 1973d, Significance of serum factors modifying cellular immune responses to growing tumours, Br. J. Cancer 28:37 (Suppl. I).
Baldwin, R. W., Price, M. R., and Robins, R. A., 1973e, Inhibition of hepatoma-immune lymph node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen, Int. J. Cancer 11:527.
Baldwin, R. W., Bowen, J. G., Embleton, M. J., Price, M. R., and Robins, R. A., 1974a, Cellular and humoral immune responses to neoantigens associated with chemically-induced tumours, in: Progress in Immunology II, Vol. 3 (L. Brent and J. Holborow, eds.), pp. 239–249, North-Holland, Amsterdam.
Baldwin, R. W., Bowen, J. G., and Price, M. R., 1974b, Solubilization of membrane-associated tumour-specific antigens by β-glucosidase, Biochim. Biophys. Acta 367:47.
Baldwin, R. W., Embleton, M. J., Price, M. R., and Vose, B. M., 1974c, Embryonic antigen expression on experimental rat tumours, Transplant. Rev. 20:77.
Baldwin, R. W., Glaves, D., and Vose, B. M., 1974d, Differentiation between the embryonic and tumour specific antigens on chemically induced rat tumours, Br. J. Cancer 29:1.
Baldwin, R. W., Glaves, D., and Vose, B. M., 1974e, Immunogenicity of embryonic antigens associated with chemically induced rat tumours, Int. J. Cancer 13:135.
Bansal, S. C., and Sjögren, H. O., 1971, “Unblocking” serum activity in vitro in the polyoma system may correlate with antitumor effects of antiserum in vivo, Nature (London) New Biol. 233:76.
Bansal, S. C., and Sjögren, H. O., 1972, Counteraction of the blocking of cell-mediated tumor immunity by inoculation of unblocking sera and splenectomy: Immunothera-peutic effects on primary polyoma tumors in rats, Int. J. Cancer 9:490.
Bartlett, G. L., 1972, Effect of host immunity on the antigenic strength of primary tumors, J. Natl. Cancer Inst. 49:493.
Bartlett, G. L., and Zbar, B., 1972, Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: Safety and efficacy, J. Natl. Cancer Inst. 48:1709.
Basombrío, M. A., 1970, Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene, Cancer Res. 30:2458.
Basombrío, M. A., and Prehn, R. T., 1972a, Antigenic diversity of tumors chemically induced within the progeny of a single cell, Int. J. Cancer 10:1.
Basombrío, M. A., and Prehn, R. T., 1972b, Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors, Natl. Cancer Inst. Monogr. 35:117.
Basombrio, M. A., and Prehn, R. T., 1972c, Search for common antigenicities between embryonic and tumoral tissue, Medicina (Arg.) 32:42.
Becker, F. F., and Sell, S., 1974, Early elevation of α 1-fetoprotein in N-2-fluorenyl-acetamide hepatocarcinogenesis, Cancer Res. 34:2489.
Belehradek, J., Barski, G., and Thonier, M., 1972, Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor: Influence of tumor growth, surgical removal and treatment with irradiated tumor cells, Int. J. Cancer 9:461.
Bloom, B. R., Bennett, B., Oettgen, H. F., McLean, E. P., and Old, L. J., 1969, Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration, Proc. Natl. Acad. Sci. U.S.A. 64:1176.
Bloom, E. T., 1970, Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene, J. Natl. Cancer Inst. 45:443.
Bloom, E. T., and Hildemann, W. H., 1970, Mechanisms of tumor-specific enhancement versus resistance toward a methylcholanthrene-induced murine sarcoma, Transplantation 10:321.
Borberg, H., Oettgen, H. F., Choudry, K., and Beattie, E. J., 1972, Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors, Int. J. Cancer 10:539.
Bowen, J. G., Robins, R. A., and Baldwin, R. W., 1975, Serum factors modifying cell mediated immunity to rat hepatoma D23 correlated with tumour status, Int. J. Cancer 15:640.
Brawn, R. J., 1970, Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas, Int. J. Cancer 6:245.
Buberík, J., Perlmann, P., Helmstein, K., and Moberger, G., 1970, Immune response to urinary bladder tumours in man, Int. J. Cancer 5:39.
Burdick, J. F., Cohen, A. M., and Wells, S. A., 1973, A simplified isotopic anti-globulin assay: Detection of tumor cell antigens, J. Natl. Cancer Inst. 50:285.
Burnet, F. M., 1970, A certain symmetry: Histocompatibility antigens compared with immunocyte receptors, Nature (London) 226:123.
Cerottini, J. C., and Brunner, K. T., 1974, Cell-mediated cytotoxicity, allograft rejection, and tumor immunity, Advan. Immunol. 18:67.
Churchill, W. H., Zbar, B., Belli, J. A., and David, J. R., 1972, Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration, J. Natl. Cancer Inst. 48:541.
Coggin, J. H., and Ambrose, K. R., 1969, A rapid in vivo assay for SV40 tumor immunity in hamsters, Proc, Soc. Exp. Biol. Med. 130:246.
Coggin, J. H., Ambrose, K. R., and Anderson, N. G., 1970, Fetal antigen capable of inducing transplantation immunity against SV40 hamster tumor cells, J. Immunol. 105:524.
Coggin, J. H., Ambrose, K. R., Bellomy, B. B., and Anderson, N. G., 1971, Tumor immunity in hamsters immunized with fetal tissues, J. Immunol. 107:526.
Colnaghi, M. I., Ménard, S., and Delia Porta, G., 1971, Demonstration of cellular immunity against urethan-induced lung adenomas of mice, J. Natl. Cancer Inst. 47: 1325.
Currie, G. A., and Alexander, P., 1974, Spontaneous shedding of TSTA by viable sarcoma cells: Its possible role in facilitating metastatic spread, Br. J. Cancer 29:72.
Currie, G. A., and Bagshawe, K. D., 1967, The masking of antigens on trophoblast and cancer cells, Lancet i:708.
Currie, G. A., and Bagshawe, K. D., 1969, Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase, Br. J. Cancer 23:141.
Delorme, E. J., and Alexander, P., 1964, Treatment of primary fibrosarcoma in the rat with immune lymphocytes, Lancet i:117.
De Vries, J. E., Rümke, P., and Bernheim, J. L., 1972, Cytotoxic lymphocytes in melanoma patients, Int. J. Cancer 9:567.
Duff, R., and Rapp, E., 1970, Reactions of serum from pregnant hamsters with surface of cells transformed by SV40, J. Immunol. 105:521.
Embieton, M. J., and Heidelberger, C., 1972, Antigenicity of clones of mouse prostate cells transformed in vitro, Int. J. Cancer 9:8.
Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13:835.
Fossati, G., Canevari, S., Delia Porta, G., Balzarini, G. P., and Veronesi, U., 1972, Cellular immunity to human breast carcinoma, Int. J. Cancer 10:391.
Globerson, A., and Feldman, M., 1964, Antigenic specificity of benzo[α]pyrene-induced sarcomas, J. Natl. Cancer Inst. 32:1229.
Gordon, J., 1965, Isoantigenicity of liver tumours induced by an azo dye, Br. J. Cancer 19:387.
Graffi, A., Pasternak, G., and Horn, K.-H., 1964, Die Erzeugung von Resistenz gegen isologe Transplantate UV-induzierter Sarkome der Maus, Acta Biol. Med. Ger. 12:725.
Graffi, A., Pasternak, G., and Hölzer, B., 1965, Erzeugung von Transplantationresistenz gegen ein syngenes UV-Sarkom durch Vorbehandlung von Mäusen mit Mitochon-drienpräparationen des gleichen Tumors, Arch. Geschwulstforsch. 26:114.
Halliday, W. J., 1971, Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens, J. Immunol. 106:855.
Halliday, W. J., and Webb, M., 1969, Delayed hypersensitivity to chemically-induced tumors in mice and correlation with an in vitro test, J. Natl. Cancer Inst. 43:141.
Harder, F. H., and McKhann, C. F., 1968, Demonstration of cellular antigens on sarcoma cells by an indirect 125I-labeled antibody technique, J. Natl. Cancer Inst. 40:231.
Heidelberger, C., 1973, Chemical oncogenesis in culture, Advan. Cancer Res. 18:317.
Hellström, I., and Hellström, K. E., 1969, Studies on cellular immunity and its serum-mediated inhibition in Moloney-virus-induced mouse sarcomas, Int. J. Cancer 4:587.
Hellström, I., and Hellström, K. E., 1975a, Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells, blocking by serum, Int. J. Cancer 15:1.
Hellström, I., and Hellström, K. E., 1975b, Cytotoxic effect of lymphocytes from multiparous mice on cultivated tumor cells. II. Blocking and unblocking of cytotoxicity, Int. J. Cancer 15:30.
Hellström, I., Hellström, K. E., and Pierce, G. E., 1968, In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methyl-cholanthrene and plastic discs, Int. J. Cancer 3:467.
Hellström, I., Hellström, K. E., and Sjögren, H. O., 1970, Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas, Cell. Immunol. 1:18.
Hellström, I., Hellström, K. E., Sjögren, H. O., and Warner, G. A., 1971a, Demonstration of cell-mediated immunity to human neoplasms of various histological types, Int. J. Cancer 7:1.
Hellström, I., Hellström, K. E., Sjögren, H. O., and Warner, G. A., 1971b, Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity, Int. J. Cancer 8:185.
Hellström, K. E., and Hellström, I., 1969, Cellular immunity against tumor antigens, Advan. Cancer Res. 12:167.
Hellström, K. E., and Hellström, I., 1970, Immunological enhancement as studied by cell culture techniques, Annu: Rev. Microbiol. 24:373.
Hellström, K. E., and Hellström, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens, Advan. Immunol. 18:209.
Herberman, R. B., Ting, C. C., Kirchner, H., Holden, H., Glaser, M., Bonnard, G. D., and Lavrin, D., 1974, Effector mechanisms in tumor immunity, in: Progress in Immunology II Vol. 3 (L. Brent and J. Holborow, eds.), pp. 285–295, North-Holland, Amsterdam.
Holmes, E. C., Kahan, B. D., and Morton, D. L., 1970, Soluble tumor-specific transplantation antigens from methylcholanthrene-induced guinea pig sarcomas, Cancer 25:373.
Holmes, E. C., Morton, D. L., Schidlovsky, G., and Trahan, E., 1971, Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas, J. Natl. Cancer Inst. 46:693.
Hopper, D. G., Pimm, M. V., and Baldwin, R. W., 1975, Methanol extraction residue of BCG in the treatment of transplanted rat tumours, Br. J. Cancer 31:176.
Horn, K.-H., Pasternak, G., and Graffi, A., 1965, Versuche zur Erzeugung tumorspezifischer Resistenz gegen isolog transplantable Sarkome, die durch Implantation von Kunststoffen erzeugt wurden, Acta Biol. Med. Ger. 15:154.
Hull, E. W., Carbone, R. P., Gitlin, D., O’Gara, R. W., and Kelly, M. G., 1969, α-Fetoprotein in monkeys with hepatoma, J. Natl. Cancer Inst. 42:1035.
Ishidate, M., 1967, Recognition of the individuality of tumour strain by sensitized peritoneal lymphoid cells, Nature (London) 215:184.
Ishidate, M., 1970, Antigenic specificity of hepatoma cell lines derived from a single rat, in: Abstracts, International Cancer Congress, Houston, p. 227.
Johnson, S., 1968, The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C57 BL mice, Br. J. Cancer 22:93.
Kim, U., 1970, Metastasizing mammary carcinomas in rats: Induction and study of their immunogenicity, Science 167: 72.
Kitagawa, T., Yokochi, T., and Sugano, H., 1972, α-Fetoprotein and hepatocarcinogene-sis in rats fed 3′-methyl-4-(dimethylamino)azo-benzene or N-2-fluorenylacetamide, Int. J. Cancer 10:368.
Klein, G., 1966, Tumor antigens, Annu. Rev. Microbiol. 20:223.
Klein, G., Sjögren, H. O., Klein, E., and Hellström, K. E., 1960, Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host, Cancer Res. 20:1561.
Klein, G., Sjögren, H. O., and Klein, E., 1963, Demonstration of host resistance against sarcomas induced by implantation of cellophane films in isologous (syngeneic) recipients, Cancer Res. 23:84.
Kroes, R., Williams, G. M., and Weisburger, J. H., 1972, Early appearance of serum α-fetoprotein during hepatocarcinogenesis as a function of age of rats and extent of treatment with 3′-methyl-4-dimethylaminoazobenzene, Cancer Res. 32:1526.
Kronman, B. S., Rapp, H. J., and Borsos, T., 1969, Tumor-specific antigens: Detection by local transfer of delayed skin hypersensitivity, J. Natl. Cancer Inst. 43:869.
Lappé, M. A., 1968, Evidence for the antigenicity of papillomas induced by 3-methylcholanthrene, J. Natl. Cancer Inst. 40:823.
Lappé, M. A., 1969, Tumour specific transplantation antigens: Possible origin in premalignant lesions, Nature (London) 223:82.
Lejneva, O. M., Zilber, L. A., and levleva, E. S., 1965, Humoral antibodies to methylcholanthrene sarcomata detected by a fluorescent technique, Nature (London) 206:1163.
Leonard, E. J., Meltzer, M. S., Borsos, T., and Rapp, H. J., 1972, Properties of tumor-specific antigen solubilized by hypertonic potassium chloride, Natl. Cancer Inst. Monogr. 35:129.
Lespinats, G., 1969, Induction d’une immunité vis-à-vis de la greffe de plasmocytosar-comes chez la souris BALB/c, Eur. J. Cancer 5:421.
Lespinats, G., 1970, Tumor-specific humoral antibodies against plasma cell tumors in immunized BALB/c mice, J. Natl. Cancer Inst. 45:845.
Mann, D. L., Fahey, J. L., and Nathenson, S. G., 1970, Molecular comparisons of papain solubilized H-2 and HL-A alloantigens, in: Histocompatibility Testing, 1970 (P. I. Terasaki, ed.), pp. 461–466, Munksgaard, Copenhagen.
Mathé, G., 1967, Antigénicité nouvelle démontrée par isogreffe d’un fragment de peau prélevé 5 jours après injection intradermique de di-methyl-benzenthracène, Rev. Fr. Etud. Clin. Biol. 12:380.
McCollester, D. L., 1970, Isolation of Meth A cell surface membranes possessing tumor-specific transplantation antigen activity, Cancer Res. 30:2832.
Meltzer, M. S., Leonard, E. J., Rapp, H. J., and Borsos, T., 1971, Tumor-specific antigen solubilized by hypertonic potassium chloride, J. Natl. Cancer Inst. 47:703.
Meltzer, M. S., Oppenheim, J. J., Littman, B. H., Leonard, E. J., and Rapp, H. J., 1972, Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor specific antigens, J. Natl. Cancer Inst. 49:727.
Mondai, S., Iype, P. T., Griesbach, L. M., and Heidelberger, C., 1970, Antigenicity of cells derived from mouse prostate after malignant transformation in vitro by carcinogenic hydrocarbons, Cancer Res. 30:1593.
Mondai, S., Embleton, M. J., Marquardt, H., and Heidelberger, C., 1971, Production of variants of decreased malignancy and antigenicity from clones transformed in vitro by methylcholanthrene, Int. J. Cancer 8:410.
Moore, M., and Williams, D. E., 1972, Studies on the antigenicity of radiation-induced murine osteosarcomata, Br. J. Cancer 26:90.
Morton, D. L., Goldman, L., and Wood, D., 1965, Tumor specific antigenicity of methylcholanthrene (MCA) and dibenzanthracene (DBA) induced sarcomas of inbred guinea pigs, Fed. Proc. 24:684.
Müller, M., 1968, Versuche zur Erzeugung einer Transplantationsimmunität gegen o-Aminoazotoluol-Hepatome bei syngenen und F1-Hybrid-Mäusen, Arch. Geschwulstforsch. 31:235.
Muramatsu, T., and Nathenson, S. G., 1971, Carbohydrate structure of mouse H-2 alloantigens, Fed. Proc. 30:691 Abs.
Oettgen, H. F., Old, L. J., McLean, E. P., and Carswell, E. A., 1968, Delayed hypsersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea pigs, Nature (London) 220:295.
Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A., 1962, Antigenic properties of chemically induced tumors, Ann. N.Y. Acad. Sci. 101:80.
Old, L. J., Boyse, E. A., and Stockert, E., 1963, Antigenic properties of experimental leukemias. I. Serological studies in vitro with spontaneous and radiation-induced leukemias, J. Natl. Cancer Inst. 31:977.
Oppenheim, J. J., Zbar, B., and Rapp, H. J., 1970, Specific inhibition of tumor cell DNA synthesis in vitro by lymphocytes from peritoneal exudate of immunized syngeneic guinea pigs, Proc. Natl. Acad. Sci. U.S.A. 66:1119.
O’Toole, C., Perlmann, P., Unsgaard, B., Moberger, G., and Edsmyr, F., 1972a, Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy, Int. J. Cancer 10:77.
O’Toole, C., Perlmann, P., Unsgaard, B., Almgard, L. E., Johansson, B., Moberger, G., and Edsmyr, F., 1972b, Cellular immunity to urinary bladder carcinoma. II. Effect of surgery and pre-operative irradiation, Int. J. Cancer 10:92.
Ozer, J. H., and Wallach, D. F. H., 1967, H-2 components and cellular membranes: Distinctions between plasma membrane and endoplasmic reticulum governed by the H-2 region in the mouse, Transplantation 5:652.
Pasternak, G., 1963, Die unterschiedliche Reaktionsfähigkeit zweier Mäuseinzucht-stämme gegen spezifische Antigene isolog transplantabler Carcinogentumoren, Acta Biol. Med. Ger. 10:572.
Pasternak, G., Graffi. A., Hoffmann, F., and Horn K.-H., 1964, Resistance against carcinomas of the skin induced by dimethylbenzanthracene (DMBA) in mice of the strain XVIVBln, Nature (London) 203:307.
Pasternak, G., Hoffmann, F., and Graffi, A., 1966, Growth of diethylnitrosamine-induced lung tumours in syngeneic mice specifically pre-treated with X-ray killed tumour tissue, Folia Biol. (Praha) 12:299.
Pilch, Y. H., 1968, The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas, Cancer Res. 28:2502.
Plata, F., and Levy, J. P., 1974, Blocking of syngeneic effector T cells by soluble tumour antigens, Nature (London) 249:271.
Poupon, M.-F., and Lespinats, G., 1972, Cell-mediated immunity directed against a syngeneic plasma cell tumor in the mouse: Detection by macrophage migration inhibition test, J. Natl. Cancer Inst. 48:1297.
Prehn, R. T., 1960, Tumor-specific immunity to transplanted dibenz[a,h]anthracene-induced sarcomas, Cancer Res. 20:1614.
Prehn, R. T., 1962, Specific isoantigenicities among chemically induced tumors, Ann. N.Y.Acad. Sci. 101:107.
Prehn, R. T., 1963, Role of immune mechanisms in the biology of chemically and physically induced tumors, in: Conceptual Advances in Immunology and Oncology, pp. 475–485, Harper and Row, New York.
Prehn, R. T., and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18:769.
Price, M. R., and Baldwin, R. W., 1974a, Preparation of aminoazo dye-induced rat hepatoma membrane fractions retaining tumour specific antigen, Br. J. Cancer 30:382.
Price, M. R., and Baldwin, R. W., 1974b, Immunogenic properties of rat hepatoma subcellular fractions, Br. J. Cancer 30:394.
Rapaport, F. T., Dausset, J., Converse, J. M., and Lawrence, H. S., 1965, Biological and ultrastructural studies of leucocyte fractions as transplantation antigens in man, Transplantation 3:490.
Reiner, J., and Southam, C. M., 1967, Evidence of common antigenic properties in chemically induced sarcomas of mice, Cancer Res. 27:1243.
Reiner, J., and Southam, C. M., 1969, Further evidence of common antigenic properties in chemically induced sarcomas of mice, Cancer Res. 29:1814.
Reisfeld, R. A., and Kahan, B. D., 1970a, Biological and chemical characterization of human histocompatibility antigens, Fed. Proc. 29:2034.
Reisfeld, R. A., and Kahan, B. D., 1970b, Transplantation antigens, Advan. Immunol. 12:117.
Reisfeld, R. A., and Kahan, B. D., 1972, Markers of biological individuality, Sci. Am. 226(6):28.
Reisfeld, R. A., Pellegrino, M. A., and Kahan, B. D., 1971, Salt extraction of soluble HL-A antigens, Science 172:1134.
Révész, L., 1960, Detection of antigenic differences in isologous host-tumor systems by pretreatment with heavily irradiated tumor cells, Cancer Res. 20:443.
Robins, R. A., and Baldwin, R. W., 1974, Tumour specific antibody neutralization of factors in rat hepatoma bearer serum which abrogate lymph node cell cytotoxicity, Int. J. Cancer 14:589.
Rosenau, W., and Morton, D. L., 1966, Tumor-specific inhibition of growth of methylcholanthrene-induced sarcomas in vivo and in vitro by sensitized isologous lymphoid cells, J. Natl. Cancer Inst. 36:825.
Ruoslahti, E., Pihko, H., and Seppälä, M., 1974, Alpha-fetoprotein: Immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease, Transplant. Rev. 20:38.
Sanderson, C. J., and Frost, P., 1974, The induction of tumour immunity in mice using glutaraldehyde-treated tumour cells, Nature (London) 248:690.
Shellam, G. R., and Knight, R. A., 1974, Antigenic inhibition of cell-mediated cytotoxicity against tumour cells, Nature (London) 252:330.
Simmons, R. L., and Rios, A., 1974, Cell surface modification in the treatment of xperimental cancer: Neuraminidase or concanavalin A, Cancer 34:1541.
Simmons, R. L., Rios, A., Ray, P. K., and Lundgren, G., 1971, Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immuno-suppressed syngeneic mice, J. Natl. Cancer Inst. 47:1087.
Sjögren, H. O., Hellström, I., Bansal, S. C., and Hellström, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci. U.S.A. 68:1372.
Sjögren, H. O., Hellström, I., Bansal, S. C., Warner, G. A., and Hellström, K. E., 1972, Elution of “blocking factors” from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes, Int. J. Cancer 9:274.
Stanislawski-Birencwajg, M., Uriel, J., and Grabar, P., 1967, Association of embryonic antigens with experimentally-induced hepatic lesions in the rat, Cancer Res. 27:1990.
Steele, G., and Sjögren, H. O., 1974, Embryonic antigens associated with chemically induced colon carcinomas in rats, Int. J. Cancer 14:435.
Stutman, O., 1972, Immunological studies on resistance to oncogenic agerts in mice, Natl. Cancer Inst. Monogr. 35:107.
Suter, L., Bloom, B. R., Wadsworth, E. M., and Oettgen, H. F., 1972, Use of the macrophage migration inhibition test to monitor fractionation of soluble antigens of chemically induced sarcomas of inbred guinea pigs, J. Immunol. 109:766.
Takasugi, M., and Klein, E., 1970, A microassay for cell-mediated immunity, Transplantation 9:219.
Takeda, K., 1969, Immunology of Cancer, Hokkaido University, Sapporo, Japan.
Takeda, K., Aizawa, M., Kituchi, Y., Yamawaki, S., and Nakamura, K., 1966, Tumour autoimmunity against methylcholanthrene-induced sarcomas of the rat, Gann 57:221.
Taranger, L. A., Chapman, W. H., Hellström, I., and Hellström, K. E., 1972a, Immunological studies on urinary bladder tumors of rats and mice, Science 176:1337.
Taranger, L. A., Hellström, I., Chapman, W. H., and Hellström, K. E., 1972b, In vitro demonstration of common tumor antigens in mouse and rat bladder carcinomas, Proc. Am. Assoc. Cancer Res. 13:56.
Thomson, D. M. P., and Alexander, P., 1973, A cross-reacting embryonic antigen in the membrane of rat sarcoma cells which is immunogenic in the syngeneic host, Br. J. Cancer 27:35.
Thomson, D. M. P., Eccles, S., and Alexander, P., 1973a, Antibodies and soluble tumour-specific antigens in blood and lymph of rats with chemically induced sarcomata, Br. J. Cancer 28:6.
Thomson, D. M. P., Sellens, V., Eccles, S., and Alexander, P., 1973b, Radioimmunoassay of tumour-specific transplantation antigen of a chemically-induced rat sarcoma: Circulating soluble antigen in tumour bearers, Br. J. Cancer 28:377.
Tuffrey, M. A., and Batchelor, J. R., 1964, Tumour specific immunity against murine epitheliomas induced with 9,10-dimethyl-l,2-benzanthracene, Nature (London) 204:349.
Vaage, J., 1971, Concomitant immunity and specific depression of immunity by residual or reinjected tumor tissue, Cancer Res. 31:1655.
Vaage, J., 1972, Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice, Cancer Res. 32:193.
Vaage, J., 1974, Circulating tumor antigens versus immune serum factors in depressed concomitant immunity, Cancer Res. 34:2979.
Vaage, J., Jones, R. D., and Brown, B. W., 1972, Tumor-specific resistance in mice detected by inhibition of macrophage migration, Cancer Res. 32:680.
Wahl, D. V., Chapman, I., Hellström, I., and Hellström, K. E., 1974, Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice, Int. J. Cancer 14:114.
Watabe, H., Hirai, H., and Satoh, H., 1972, α-Fetoprotein in rats transplanted with ascites hepatoma, Gann 63:189.
Wepsic, H. T., Zbar, B., Rapp, H. J., and Borsos, T., 1970, Systemic transfer of tumor immunity: Delayed hypersensitivity and suppression of tumor growth, J. Natl. Cancer Inst. 44:955.
Wolf, A., and Avis, P. J. G., 1970, Preparation and purification of plasma membranes from murine lymphoma cells carrying tumour-specific antigenicity, Transplantation 9:18.
Zbar, B., Wepsic, H. T., Rapp, H. J., Borsos, T., Kronman, B. S., and Churchill, W. H., 1969, Antigenic specificity of hepatomas induced in strain 2 guinea pigs by diethylnitrosamine, J. Natl. Cancer Inst. 43:833.
Zbar, B., Wepsic, H. T., Rapp, H. J., Stewart, L. C., and Borsos, T., 1970, Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils, J. Natl. Cancer Inst. 44:701.
Zbar, B., Bernstein, I. D., and Rapp, H. J., 1971, Suppression of tumor growth at the site of infection with living bacillus Calmette Guérin, J. Natl. Cancer Inst. 46:831.
Zbar, B., Bernstein, I. D., Bartlett, G. L., Hanna, G., and Rapp, H. J., 1972a, Immunotherapy of cancer: Regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis, J. Natl. Cancer Inst. 49:119.
Zbar, B., Rapp, H. J., and Ribi, E. E., 1972b, Tumor suppression by cell walls of Mycobacterium bovis attached to oil droplets, J. Natl. Cancer Inst. 48:831.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Baldwin, R.W., Price, M.R. (1976). Cell Membrane Associated Antigens in Chemical Carcinogenesis. In: Manson, L.A. (eds) Biomembranes. Biomembranes, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-9087-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9087-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-9089-3
Online ISBN: 978-1-4684-9087-9
eBook Packages: Springer Book Archive